Congratulations to .............................
Wednesday 15 June 2011
Philippa Dobby and Margaret Dobby’s Utah VII who finished runners up in the 23,000€ Grand Prix at CSI2* Mantes la Jolie FRA.
Laura Renwick and Roller Coaster III, owned by John and Marian Renwick who finished in second place in the 40,000€ Grand Prix at CSI3* Bethune FRA.
Team Talk…….
The Team competes in the Nations Cup in Drammen NOR this coming Saturday (18th June). You can follow the results at www.springtour.no
IMPORTANT: Charles Stanley British Masters at South View
Those of you who have received an invitation to the Charles Stanley British Masters taking place at South View EC from the 1st – 3rd July please contact South View immediately to confirm your entries .
Changes to the National Equine Anti Doping and Controlled Medication Rules
The British Equestrian Federation has announced a new set of National Equine Anti Doping and Controlled Medication rules (BEFAR).
The new rules, which closely mirror the FEI guidelines, will affect all BEF Member Bodies which are FEI disciplines and will be incorporated into their rules on publication of their forthcoming rulebooks.
All disciplines will be fully compliant by 1st January 2012. The BEF Member Bodies concerned have welcomed this standardised system, which will create a clear policy for all members across those disciplines, with all adhering to the same prohibited substances list, sanctions and procedures. British Showjumping will be the first to join the system on 1st April 2011.
The new system will see an increasing number of anti-doping tests across the disciplines and all affiliated members should expect their horse to be tested, whether they are competing at grass roots level or at a National Championship. The Equine Anti Doping and Controlled Medication Rules for international competitors remain unchanged.
The new rules, which have been instigated by the FEI, apply to all National Federations, with the deadline for compulsory compliance for Federations set at 1st January 2012. It is hoped that the creation of standardised national guidelines will make things clearer for riders, particularly those that compete in more than one discipline. Once all of the FEI disciplines introduce the new rules, the prohibited substances, procedures and sanctions will be the same, whatever the discipline someone is competing in.
It is important to note that the new system, in line with the FEI, adopts their prohibited substances list in its entirety, including a ban on Non-Steroidal Anti Inflammatory Drugs (NSAIDs). Under the new National system, these will be classed as Controlled Medications, which, if found in a horse’s sample during competition, will result in a violation. BEFAR is supported and funded by all BEF Member Bodies and UK Anti Doping (UKAD).
The BEFAR and prohibited substances list can be found on the BEF website under the Information for Competitors section.
FEI ANNOUNCES DETECTION TIMES FOR MELOXICAM
The FEI has announced detection times for Meloxicam (veterinary formulation known as Metacam®), a non-steroidal anti-inflammatory drug (NSAID) used to relieve pain and inflammation in the equine athlete.
The detection time is the time taken for an active substance administered to a horse by a specified route and dosage to fall below a level that FEI-approved laboratories would declare a sample positive. It is important to note that detection times may vary depending on dose and number of injection sites used.
The findings of studies on the use of intravenously or orally administered Meloxicam show the urine and plasma (blood) detection time as 72 hours1.
This is the first COX-2 inhibitor on the FEI List of Detection Times, which contains common medications administered out of competition and is listed on the FEI Clean Sport website.
“We are committed to providing the tools to assist our athletes to adhere to the FEI’s Equine Anti-Doping Rules, and will add further medication detection times over the coming 12 months,” explains Graeme Cooke, Director of Veterinary Department at the FEI.
Meloxicam (Metacam®) is developed by Boehringer-Ingelheim.
1 Detection Time agreed with the European Horse Racing Scientific Liaison Committee (EHSLC)
| Recent East News | |
|---|---|
1daqxgvln99ql.jpg "Equine Influenza Update") |
Equine Influenza Update 21/05/2026 |
 |
Barleylands Ariat Novice Second Round 29/04/2026 |
 |
Barleylands Nupafeed Supplements Discovery Second Round 29/04/2026 |
 |
Ruby Couzens from Bedfordshire is the latest British Showjumping Shining Star 31/03/2026 |
 |
POYS Entries 12/03/2026 |